GOF amends equity distribution agreement; may sell up to $330M in common shares via Cantor Fitzgerald

GUGGENHEIM STRATEGIC OPPORTUNITIES FUND

Third amendment to Controlled Equity Offering Sales Agreement with Cantor Fitzgerald effective March 27, 2023.
Aggregate offering price up to $330,024,727, replacing previous $374,537,331 cap.
Offering commenced March 28, 2023 under existing shelf registration statement (File No. 333-259592).
Common shares (NYSE: GOF) may be sold from time to time at market prices through agent Cantor Fitzgerald.
No minimum or maximum number of shares specified; terms determined by mutual agreement.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

GUGGENHEIM STRATEGIC OPPORTUNITIES FUND amended Sales Agreement with Cantor Fitzgerald & Co. valued at up to $330,024,727 (effective 2023-03-27).

Action: amendment
Agreement: atm program
Counterparty: Cantor Fitzgerald & Co.
Value: up to $330,024,727
Effective: 2023-03-27

Exact text from the filing

Guggenheim Strategic Opportunities Fund (NYSE: GOF) (the “Fund”) has entered into a Controlled Equity Offering SM Sales Agreement, dated July 1, 2019, as amended by First Amendment to Controlled Equity Offering SM Sales Agreement, dated February 1, 2021, Second Amendment to Controlled Equity Offering SM Sales Agreement, dated September 16, 2021, and Third Amendment to Controlled Equity Offering SM Sales Agreement, dated March 27, 2023 (as amended, the “Sales Agreement”) by and among the Fund, Guggenheim Funds Investment Advisors, LLC, and Cantor Fitzgerald & Co.

View on SEC.gov

Browse all material agreements →

GUGGENHEIM STRATEGIC OPPORTUNITIES FUND filing history →

Source: SEC EDGAR

accession 0001193125-23-097503

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.